BEHÄLTER FÜR ABGEMESSENE DOSIERUNGEN

European patent · EP3080562 · Deleted

Register entry

Publication number
EP3080562
Application number
EP14869564
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 11, 2014
Published
Oct 19, 2016
Granted
Aug 1, 2018
Deleted
Dec 31, 2018
Reason
Annual fee unpaid
IPC classes
A61J 1/00 (2006.01)
Priority
IN 3636DE2013 13.12.2013
PCT application
PCT/US2014/069685 11.12.2014
PCT publication
WO2015/089260 18.06.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 17, 2019

    Deleted, fee unpaid

    Published in Swissreg on 17.07.2019

  2. Aug 1, 2018

    Granted

    Published in Swissreg on 01.08.2018

Parties

Holder

GlaxoSmithKline LLC

251 Little Falls Drive, Wilmington, DE 19808, US

Inventor

SABHARWAL, Amit

Gurgaon 122001, IN

SAINI, Sukhdev Singh

Gurgaon 122001, IN

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.